<DOC>
	<DOCNO>NCT01568879</DOCNO>
	<brief_summary>The aim study test effectiveness pharmacist-staffed , protocol-based chronic disease management program compare patient receive usual care achieve target serum uric acid level patient recurrent gout .</brief_summary>
	<brief_title>Evaluating Effectiveness Chronic Disease Management Program Gout</brief_title>
	<detailed_description>Gout chronic condition intermittent symptom manage outcome-based disease management approach . Unlike common chronic condition , strategy population management gout patient test . The study identify adult member Kaiser Permanente ( KP ) Northern California diagnosis gout 3 outpatient Emergency Department visit gout 1-year period precede study enrollment . These patient randomize either active management group , usual care . The participant enrol followed period 26 week . The primary outcome measure attainment maintenance uric acid lower regimen target achieve serum uric acid level 6.0 mg/dl less . The treatment protocol use standard treatment guideline low maintain uric acid level less equal 6.0 mg/dl ( maximum dos uric acid lower medication ) provide patient education dietary counseling . Monitoring medication management carry licensed clinical pharmacist supervision experience rheumatologist . Control subject regular monitoring serum uric acid level provide educational material dietary counseling , otherwise receive usual care . The demonstration chronic disease management approach gout care improve health reduce morbidity patient gout may illuminate simple path towards improve quality life reduce morbidity grow population patient .</detailed_description>
	<mesh_term>Gout</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Three outpatient/ED visit 24month period prior selection study one primary visit diagnosis : Gouty arthropathy Gout , unspecified Gout specify manifestation Tophaceous gout ear ( 274.81 ) site Gouty nephropathy At least 2 year continuous Kaiser Foundation Hospital Plan membership Baseline uric acid level 7.0mg/dl Current cancer diagnosis active treatment End stage renal disease Pregnant lactating Patients diagnosis dementia Terminally ill patient</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Recurrent gout</keyword>
	<keyword>Tophaceous gout</keyword>
	<keyword>Gout flare</keyword>
	<keyword>Arthritis</keyword>
	<keyword>Joint Diseases</keyword>
	<keyword>Rheumatic Diseases</keyword>
</DOC>